Literature DB >> 19284971

Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress.

Jeff S Isenberg1, Yan Qin, Justin B Maxhimer, John M Sipes, Daryl Despres, Jurgen Schnermann, William A Frazier, David D Roberts.   

Abstract

Nitric oxide (NO) locally regulates vascular resistance and blood pressure by modulating blood vessel tone. Thrombospondin-1 signaling via its receptor CD47 locally limits the ability of NO to relax vascular smooth muscle cells and increase regional blood flow in ischemic tissues. To determine whether thrombospondin-1 plays a broader role in central cardiovascular physiology, we examined vasoactive stress responses in mice lacking thrombospondin-1 or CD47. Mice lacking thrombospondin-1 exhibit activity-associated increases in heart rate, central diastolic and mean arterial blood pressure and a constant decrease in pulse pressure. CD47-deficient mice have normal central pulse pressure but elevated resting peripheral blood pressure. Both null mice show exaggerated decreases in peripheral blood pressure and increased cardiac output and ejection fraction in response to NO. Autonomic blockade also induces exaggerated hypotensive responses in awake thrombospondin-1 null and CD47 null mice. Both null mice exhibit a greater hypotensive response to isoflurane, and autonomic blockage under isoflurane anesthesia leads to premature death of thrombospondin-1 null mice. Conversely, the hypertensive response to epinephrine is attenuated in thrombospondin-1 null mice. Thus, the matricellular protein thrombospondin-1 and its receptor CD47 serve as acute physiological regulators of blood pressure and exert a vasopressor activity to maintain global hemodynamics under stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19284971      PMCID: PMC2663008          DOI: 10.1016/j.matbio.2009.01.002

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  47 in total

1.  Predictors of hypotension after induction of general anesthesia.

Authors:  David L Reich; Sabera Hossain; Marina Krol; Bernard Baez; Puja Patel; Ariel Bernstein; Carol A Bodian
Journal:  Anesth Analg       Date:  2005-09       Impact factor: 5.108

2.  Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.

Authors:  Jeff S Isenberg; Lisa A Ridnour; Elizabeth M Perruccio; Michael G Espey; David A Wink; David D Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

Review 3.  Vascular extracellular matrix and aortic development.

Authors:  Cassandra M Kelleher; Sean E McLean; Robert P Mecham
Journal:  Curr Top Dev Biol       Date:  2004       Impact factor: 4.897

4.  CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.

Authors:  Jeff S Isenberg; Lisa A Ridnour; Julie Dimitry; William A Frazier; David A Wink; David D Roberts
Journal:  J Biol Chem       Date:  2006-07-11       Impact factor: 5.157

5.  The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size.

Authors:  Jeffrey I Zwicker; Flora Peyvandi; Roberta Palla; Rossana Lombardi; Maria Teresa Canciani; Andrea Cairo; Diego Ardissino; Luisa Bernardinelli; Kenneth A Bauer; Jack Lawler; Pier Mannucci
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

6.  Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses.

Authors:  Jeff S Isenberg; David A Wink; David D Roberts
Journal:  Cardiovasc Res       Date:  2006-05-27       Impact factor: 10.787

7.  Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries.

Authors:  Jessica E Wagenseil; Nandan L Nerurkar; Russell H Knutsen; Ruth J Okamoto; Dean Y Li; Robert P Mecham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-04-29       Impact factor: 4.733

8.  Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.

Authors:  Jeff S Isenberg; Fuminori Hyodo; Ken-Ichiro Matsumoto; Martin J Romeo; Mones Abu-Asab; Maria Tsokos; Periannan Kuppusamy; David A Wink; Murali C Krishna; David D Roberts
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

Review 9.  Nitric oxide in hypertension.

Authors:  Matthias Hermann; Andreas Flammer; Thomas F Lüscher
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

10.  Integrin-associated protein stimulates alpha2beta1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases.

Authors:  X Q Wang; F P Lindberg; W A Frazier
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

View more
  51 in total

1.  Cardiac-specific NRAP overexpression causes right ventricular dysfunction in mice.

Authors:  Shajia Lu; Garland L Crawford; Justin Dore; Stasia A Anderson; Daryl Despres; Robert Horowits
Journal:  Exp Cell Res       Date:  2011-01-26       Impact factor: 3.905

Review 2.  The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.

Authors:  David D Roberts; Thomas W Miller; Natasha M Rogers; Mingyi Yao; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

Review 3.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

Review 4.  The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Pediatr Nephrol       Date:  2018-11-03       Impact factor: 3.714

5.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

Review 6.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

7.  Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.

Authors:  Mingyi Yao; David D Roberts; Jeff S Isenberg
Journal:  Pharmacol Res       Date:  2010-10-29       Impact factor: 7.658

Review 8.  Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

Authors:  Natasha M Rogers; Kedar Ghimire; Maria J Calzada; Jeffrey S Isenberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

9.  (-)-Epicatechin is associated with increased angiogenic and mitochondrial signalling in the hindlimb of rats selectively bred for innate low running capacity.

Authors:  Maik Hüttemann; Icksoo Lee; Guy A Perkins; Steven L Britton; Lauren G Koch; Moh H Malek
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

10.  Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.

Authors:  Thomas W Miller; Sukhbir Kaur; Kelly Ivins-O'Keefe; David D Roberts
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.